It’s only diagnostically relevant in the context of imprecise population categories, lack of knowledge about disease origins, and the absence of genetic testing for conditions (i.e not in 2024). As others have pointed out in this thread, for example, the conflation of Black with prone to sickle cell disease is erroneous and more correctly determined by ancestry proximate to the region of the disease’s origin. Similarly, “white” in the US includes a wide swathe of genetics with various degrees of predisposition to melanoma (e.g. Northern vs Southern European).